Literature DB >> 23334205

The recruitment of patients to trials in head and neck cancer: a qualitative study of the EaStER trial of treatments for early laryngeal cancer.

D W Hamilton1, I de Salis, J L Donovan, M Birchall.   

Abstract

We aimed to investigate the factors contributing to poor recruitment to the EaStER trial "Early Stage glottic cancer: Endoscopic excision or Radiotherapy" feasibility study. We performed a prospective qualitative assessment of the EaStER trial at three centres to investigate barriers to recruitment and implement changes. Methods used included semi-structured interviews, focus groups and audio-recordings of recruitment encounters. First, surgeons and recruiters did not all accept the primary outcome as the rationale for the trial. Surgeons did not always adhere to the trial eligibility criteria leading to variations between centres in the numbers of "eligible" patients. Second, as both treatments were considered equally successful, recruiters and patients focused on the pragmatics of the different trial arms, favouring surgery over radiotherapy. The lack of equipoise was reflected in the way recruiters presented trial information. Third, patient views, beliefs and preferences were not fully elicited or addressed by recruiters. Fourth, in some centres, logistical issues made trial participation difficult. This qualitative research identified several major issues that explained recruitment difficulties. While there was insufficient time to address these in the EaStER trial, several factors would need to be addressed to launch further RCTs in head and neck cancer. These include the need for clear ongoing agreement among recruiting clinicians regarding details in the study protocol; an understanding of the logistical issues hindering recruitment at individual centres; and training recruiters to enable them to explain the need for randomisation and the rationale for the RCT to patients.

Entities:  

Mesh:

Year:  2013        PMID: 23334205     DOI: 10.1007/s00405-013-2349-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  24 in total

1.  Evidence-based medicine in otolaryngology journals.

Authors:  Boris L Bentsianov; Marina Boruk; Richard M Rosenfeld
Journal:  Otolaryngol Head Neck Surg       Date:  2002-04       Impact factor: 3.497

Review 2.  A systematic review of reasons for nonentry of eligible patients into surgical randomized controlled trials.

Authors:  Ned S Abraham; Jane M Young; Michael J Solomon
Journal:  Surgery       Date:  2006-04       Impact factor: 3.982

Review 3.  Voice-related quality of life in T1 glottic cancer: irradiation versus endoscopic excision.

Authors:  Seth M Cohen; C Gaelyn Garrett; William D Dupont; Robert H Ossoff; Mark S Courey
Journal:  Ann Otol Rhinol Laryngol       Date:  2006-08       Impact factor: 1.547

4.  Vocal function following laser and conventional surgery of small malignant vocal fold tumours.

Authors:  A Keilmann; W Bergler; M Artzt; K Hörmann
Journal:  J Laryngol Otol       Date:  1996-12       Impact factor: 1.469

Review 5.  Limitations of randomized clinical trials for evaluating emerging operations: the case of lung volume reduction surgery.

Authors:  R L Berger; B R Celli; A L Meneghetti; P H Bagley; C D Wright; E P Ingenito; A Gray; G L Snider
Journal:  Ann Thorac Surg       Date:  2001-08       Impact factor: 4.330

6.  Vocal function following carbon dioxide laser surgery for glottic carcinoma.

Authors:  M Hirano; Y Hirade; H Kawasaki
Journal:  Ann Otol Rhinol Laryngol       Date:  1985 May-Jun       Impact factor: 1.547

Review 7.  A clinical audit of glottic cancer in Nova Scotia: a paradigm for effectiveness research.

Authors:  S M Sagar; G McKenna; M C Nolan
Journal:  Clin Oncol (R Coll Radiol)       Date:  1994       Impact factor: 4.126

Review 8.  Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer.

Authors:  P Dey; D Arnold; R Wight; K MacKenzie; C Kelly; J Wilson
Journal:  Cochrane Database Syst Rev       Date:  2002

Review 9.  Quality improvement report: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Commentary: presenting unbiased information to patients can be difficult.

Authors:  Jenny Donovan; Nicola Mills; Monica Smith; Lucy Brindle; Ann Jacoby; Tim Peters; Stephen Frankel; David Neal; Freddie Hamdy
Journal:  BMJ       Date:  2002-10-05

10.  Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011).

Authors:  Sangeetha Paramasivan; Robert Huddart; Emma Hall; Rebecca Lewis; Alison Birtle; Jenny L Donovan
Journal:  Trials       Date:  2011-03-15       Impact factor: 2.279

View more
  22 in total

1.  Curcumin inhibits cell proliferation and promotes apoptosis of laryngeal cancer cells through Bcl-2 and PI3K/Akt, and by upregulating miR-15a.

Authors:  Shaofeng Mou; Zhongxin Zhou; Yukai He; Fuxing Liu; Lili Gong
Journal:  Oncol Lett       Date:  2017-08-10       Impact factor: 2.967

2.  Current treatment of T1N0 squamous cell carcinoma of the glottic larynx.

Authors:  William M Mendenhall; Robert P Takes; Jatin P Shah; Patrick J Bradley; Jonathan J Beitler; Primož Strojan; Carlos Suárez; Juan P Rodrigo; Nabil F Saba; Alessandra Rinaldo; Jochen A Werner; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-11-08       Impact factor: 2.503

Review 3.  Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer.

Authors:  Laura Warner; Jessal Chudasama; Charles G Kelly; Sean Loughran; Kenneth McKenzie; Richard Wight; Paola Dey
Journal:  Cochrane Database Syst Rev       Date:  2014-12-12

4.  Understanding the perspectives of recruiters is key to improving randomised controlled trial enrolment: a qualitative evidence synthesis.

Authors:  Nicola Farrar; Daisy Elliott; Catherine Houghton; Marcus Jepson; Nicola Mills; Sangeetha Paramasivan; Lucy Plumb; Julia Wade; Bridget Young; Jenny L Donovan; Leila Rooshenas
Journal:  Trials       Date:  2022-10-20       Impact factor: 2.728

5.  Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.

Authors:  Freddie C Hamdy; Jenny L Donovan; J Athene Lane; Malcolm Mason; Chris Metcalfe; Peter Holding; Julia Wade; Sian Noble; Kirsty Garfield; Grace Young; Michael Davis; Tim J Peters; Emma L Turner; Richard M Martin; Jon Oxley; Mary Robinson; John Staffurth; Eleanor Walsh; Jane Blazeby; Richard Bryant; Prasad Bollina; James Catto; Andrew Doble; Alan Doherty; David Gillatt; Vincent Gnanapragasam; Owen Hughes; Roger Kockelbergh; Howard Kynaston; Alan Paul; Edgar Paez; Philip Powell; Stephen Prescott; Derek Rosario; Edward Rowe; David Neal
Journal:  Health Technol Assess       Date:  2020-08       Impact factor: 4.014

6.  Liver resection surgery compared with thermal ablation in high surgical risk patients with colorectal liver metastases: the LAVA international RCT.

Authors:  Brian Davidson; Kurinchi Gurusamy; Neil Corrigan; Julie Croft; Sharon Ruddock; Alison Pullan; Julia Brown; Maureen Twiddy; Jaqueline Birtwistle; Stephen Morris; Nick Woodward; Steve Bandula; Daniel Hochhauser; Raj Prasad; Steven Olde Damink; Marielle Coolson; K van Laarhoven; Johannes Hw de Wilt
Journal:  Health Technol Assess       Date:  2020-04       Impact factor: 4.014

7.  Using qualitative methods in pilot and feasibility trials to inform recruitment and retention processes in full-scale randomised trials: a qualitative evidence synthesis.

Authors:  Adel Elfeky; Shaun Treweek; Karin Hannes; Hanne Bruhn; Cynthia Fraser; Katie Gillies
Journal:  BMJ Open       Date:  2022-04-18       Impact factor: 3.006

8.  A simple technique to identify key recruitment issues in randomised controlled trials: Q-QAT - Quanti-Qualitative Appointment Timing.

Authors:  Sangeetha Paramasivan; Sean Strong; Caroline Wilson; Bruce Campbell; Jane M Blazeby; Jenny L Donovan
Journal:  Trials       Date:  2015-03-11       Impact factor: 2.279

9.  Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platform.

Authors:  Shaun Treweek; Doug G Altman; Peter Bower; Marion Campbell; Iain Chalmers; Seonaidh Cotton; Peter Craig; David Crosby; Peter Davidson; Declan Devane; Lelia Duley; Janet Dunn; Diana Elbourne; Barbara Farrell; Carrol Gamble; Katie Gillies; Kerry Hood; Trudie Lang; Roberta Littleford; Kirsty Loudon; Alison McDonald; Gladys McPherson; Annmarie Nelson; John Norrie; Craig Ramsay; Peter Sandercock; Daniel R Shanahan; William Summerskill; Matt Sydes; Paula Williamson; Mike Clarke
Journal:  Trials       Date:  2015-06-05       Impact factor: 2.279

10.  Barriers and opportunities for enhancing patient recruitment and retention in clinical research: findings from an interview study in an NHS academic health science centre.

Authors:  Mary Adams; Louise Caffrey; Christopher McKevitt
Journal:  Health Res Policy Syst       Date:  2015-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.